Reduced PCR-generated errors from a hybrid capture-based NGS assay for HLA typing

被引:6
|
作者
Brown, Nicholas K. [1 ]
Merkens, Hanneke [2 ]
Rozemuller, Erik H. [2 ]
Bell, Derrick [1 ]
Bui, Thanh-Mai [1 ]
Kearns, Jane [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] GenDx, Yalelaan 48, NL-3584 CM Utrecht, Netherlands
关键词
HLA typing; NGS; PCR errors; Hybrid-capture;
D O I
10.1016/j.humimm.2021.02.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Next generation sequencing (NGS) assays are state of the art for HLA genotyping. To sequence on an Illumina sequencer, the DNA of interest must be enriched, fragmented, and bookended with known oligonucleotide sequences, a process known as library construction. Many HLA genotyping assays enrich the target loci by long-range PCR (LR-PCR), prior to fragmentation. This PCR step has been reported to introduce errors in the DNA to be sequenced, including inaccurate replication of repeated sequences, and the in vitro recombination of alleles encoded on separate chromosomes. An alternative library construction method involves fragmentation of genomic DNA, followed by hybrid-capture (HC) enrichment of target HLA loci. This HC-based method involves PCR, but with far fewer cycles. Consequently, the HC method had significantly fewer PCR-induced errors, including more faithful replication of repeated sequences, and the near elimination of recombinant sequences. These improvements likely produce more accurate NGS sequencing data of HLA loci. (c) 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 50 条
  • [21] Analysis of Estrogen Receptor (ER) Immunohistochemistry in Breast Cancer with ESR1 Mutations Detected by Hybrid Capture-Based Next Generation Sequencing (NGS)
    Ross, Dara S.
    Konno, Fumiko
    Brogi, Edi
    Zehir, Ahmet
    Berger, Michael F.
    Chandarlapaty, Sarat
    Razavi, Pedram
    Baselga, Jose
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2016, 29 : 69A - 69A
  • [22] Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer
    Shen, Wenbin
    Shan, Boer
    Liang, Shanhui
    Zhang, Junling
    Yu, Yangyang
    Zhang, Yuzi
    Wang, Guoqiang
    Bai, Yuezong
    Qian, Bing
    Lu, Jin
    Jiang, Zhi
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [23] Comprehensive Assessment of Targetable Driver Alterations in Lung Adenocarcinomas Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
    Arcila, Maria
    Zehir, Ahmet
    Cheng, Donavan
    Yu, Helena
    Kris, Marc
    Drilon, Alexander
    Riely, Gregory
    Boger, Michael
    Ladanyi, Marc
    MODERN PATHOLOGY, 2015, 28 : 511A - 511A
  • [24] Comprehensive Assessment of Targetable Driver Alterations in Lung Adenocarcinomas Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
    Arcila, Maria
    Zehir, Ahmet
    Cheng, Donavan
    Yu, Helena
    Kris, Marc
    Drilon, Alexander
    Riely, Gregoty
    Berger, Michael
    Ladanyi, Marc
    LABORATORY INVESTIGATION, 2015, 95 : 511A - 511A
  • [25] Hybrid capture-based genomic profiling of circulating tumor DNA from patients with metastatic breast cancer.
    Guan, Xiaoxiang
    Zhu, Hong
    Xie, Wenzhuan
    Zhao, Jing
    Wang, Guoqiang
    Zhang, Yuzi
    Zhao, Zhengyi
    Cai, Shangli
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Analysis of Estrogen Receptor (ER) Immunohistochemistry (IHC) in Breast Cancer with ESR1 Mutations Detected by Hybrid Capture-Based Next Generation Sequencing (NGS)
    Ross, Dara S.
    Konno, Fumiko
    Brogi, Edi
    Zehir, Ahmet
    Berger, Michael F.
    Chandarlapaty, Sarat
    Razavi, Pedram
    Baselga, Jose
    Wen, Hannah Y.
    LABORATORY INVESTIGATION, 2016, 96 : 69A - 69A
  • [27] BEYOND HLA-NGS: ALLOSEQ TX 8 NOVEL HYBRID CAPTURE APPROACH FOR HIGH THROUGHPUT VOLUNTEER DONOR TYPING WITH EXPANDABLE GENE CONTENT INCLUDING ABO
    Norton, John E.
    Hogan, Hayley M.
    Dallas, Peter B.
    Newbound, Chris N.
    Kolanski, Supaneda N.
    Goodridge, Damian M.
    Sayer, David C.
    HUMAN IMMUNOLOGY, 2020, 81 : 40 - 40
  • [28] Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced hepatocellular carcinoma.
    Li, Mao
    Wei, Ailin
    Xie, Wenzhuan
    Zhao, Jing
    Zhao, Zhenqyi
    Zhang, Yuzi
    Wang, Guogiang
    Cai, Shangli
    Li, Ang
    Cao, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Mining Large Panel Hybrid Capture-Based Clinical NGS Data for Novel Virus Pathogen-Tumor Associations Based on Mapping of Off-Target Reads to Viral Genomes
    Vanderbilt, Chad M.
    Reichel, Jonathan
    Zehir, Ahmet
    Arcila, Maria
    Dogan, Snjezana
    Ladanyi, Marc
    Middha, Sumit
    LABORATORY INVESTIGATION, 2018, 98 : 709 - 709
  • [30] Hybrid capture-based next-generation sequencing (HC NGS) in melanoma to identify markers of response to anti-PD-1/PD-L1.
    Johnson, Douglas Buckner
    Frampton, Garrett Michael
    Rioth, Matthew J.
    Yusko, Erik
    Ennis, Riley
    Fabrizio, David
    Greenbowe, Joel R.
    Ali, Siraj Mahamed
    Frederick, Dennie T.
    Puzanov, Igor
    Balko, Justin M.
    Cates, Justin
    Ross, Jeffrey S.
    Robins, Harlan
    Miller, Vincent A.
    Stephens, Phil
    Sullivan, Ryan. J.
    Sosman, Jeffrey Alan
    Lovly, Christine Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)